This week, the GOLD team discusses key articles and themes from the latest magazine, drilling down into topics such as what pharma can learn from the tech giants, the industry's response to Roe v. Wade and the delicate balance of biotech success, to give listeners some exclusive context and insights on three fascinating stories affecting the industry today.

If you're interested in learning more about the topic areas discussed in this episode, check out the following content:

Following in the footsteps of tech giants https://www.emg-gold.com/post/following-in-the-footsteps-of-tech-giants

Pharma's response to Roe v. Wade https://www.emg-gold.com/post/pharma-s-response-to-roe-v-wade

Is the biotech boom on thin ice? https://www.emg-gold.com/post/is-the-biotech-boom-on-thin-ice

Decentralised clinical trials: going green https://www.emg-gold.com/post/decentralised-clinical-trials-going-green

S03 E09: Pharma insights from the team behind GOLD